Therapy effects of green tea in a patient with systemic light-chain amyloidosis (Q50644048)

From Wikidata

Jump to navigation Jump to search

scientific article published on 3 March 2008

Language	Label	Description	Also known as
English	Therapy effects of green tea in a patient with systemic light-chain amyloidosis	scientific article published on 3 March 2008

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/18317666

Therapy effects of green tea in a patient with systemic light-chain amyloidosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/18317666

1

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/18317666

2

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/18317666

3

object named as

Hugo A Katus

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/18317666

publication date

3 March 2008

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/18317666

Clinical Research in Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/18317666

97

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/18317666

5

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/18317666

341-344

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/18317666

M-mode and two-dimensional echocardiographic features in cardiac amyloidosis

1 reference

https://api.crossref.org/works/10.1007%2FS00392-008-0649-6

21 January 2018

Design, semisynthesis, and evaluation of O-acyl derivatives of (-)-epigallocatechin-3-gallate as antitumor agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/18317666

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ADAM10 activation is required for green tea (-)-epigallocatechin-3-gallate-induced alpha-secretase cleavage of amyloid precursor protein

1 reference

https://pubmed.ncbi.nlm.nih.gov/18317666

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Longitudinal Myocardial Function Assessed by Tissue Velocity, Strain, and Strain Rate Tissue Doppler Echocardiography in Patients With AL (Primary) Cardiac Amyloidosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18317666

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolism of green tea catechins: an overview

1 reference

https://pubmed.ncbi.nlm.nih.gov/18317666

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18317666

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18317666

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transdermal delivery of (-)-epigallocatechin-3-gallate, a green tea polyphenol, in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/18317666

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Eprodisate for the treatment of renal disease in AA amyloidosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18317666

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Advances in the treatment of amyloidosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18317666

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epigallocathechin-3-gallate in AL amyloidosis: a new therapeutic option?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18317666

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term survival in a patient with AL amyloidosis after cardiac transplantation followed by autologous stem cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18317666

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A novel prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate as a potential anticancer agent

1 reference

https://pubmed.ncbi.nlm.nih.gov/18317666

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical effects of oral green tea extracts in four patients with low grade B-cell malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/18317666

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18317666

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00392-008-0649-6

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/18317666

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/18317666

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50644048&oldid=2255744336"